Article
An economic evaluation of short-term inpatient rehabilitation for children with severe asthma.
Jefferson Medical College, Division of Allergy and Clinical Immunology, Alfred I. duPont Institute, Wilmington, DE 19899, USA.
Journal of Allergy and Clinical Immunology (impact factor:
11).
09/1996;
98(2):264-73.
pp.264-73
Source: PubMed
-
Citations (0)
- Cited In (1)
-
Article: Costs of asthma according to the degree of severity.
[show abstract] [hide abstract]
ABSTRACT: An increase in asthma-related morbidity and mortality has been reported recently, resulting in a substantial increase in the economic impact of this condition. Little information is available relating to the costs of asthma depending on the degree of severity of the disease. Total, direct and indirect costs generated by asthma patients who sought medical care for asthma control over a one-year period in a northern area of Spain were determined. Data were obtained from the patients themselves and severity of illness was classified into mild, moderate and severe according to the International Consensus Report on Diagnosis and Treatment of Asthma, 1992. The average total annual asthma-derived cost was estimated at US$2,879 per patient, with averages of US$1,336 in mildly asthmatic patients, US$2,407 in moderate asthma and US$6,393 in severe asthma. At all levels of severity, indirect costs were twice as high as direct costs, and at the same degree of severity, direct costs due to medication and hospitalization were higher among females than males. A minority of severe asthmatics incurred some 41% of the total costs. The cost of asthma was surprisingly high and varied substantially depending on the degree of severity of the disease. Further knowledge of the costs of asthma across various levels of severity will contribute to a better characterization of optimal intervention strategies for asthma care.European Respiratory Journal 01/1999; 12(6):1322-6. · 5.89 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
1-year period
4-year follow-up period
4-year postrehabilitation period
6.2 billion dollars
Asthma resource use
control group
discounted cumulative net savings surpassed
first year
fourth year
fourth years
mean rehabilitation charge
median asthma resource use 1 year
median emergency care
medical charges
own controls
postrehabilitation period
second year
severe asthma 1 year
third year
total medical charges